- 著者
-
DECENZO MAUREEN
KURANDA MIKE
COHEN SETH
BABIAK JOHN
JIANG ZHI-DONG
SUN DONGYU
HICKEY MARK
SANCHETI PRAVEEN
BRADFORD PATRICIA A.
YOUNGMAN PHIL
PROJAN STEVE
ROTHSTEIN DAVID M.
- 出版者
- 公益財団法人 日本感染症医薬品協会
- 雑誌
- The Journal of Antibiotics
- 巻号頁・発行日
- vol.55, no.3, pp.288-295, 2002
- 被引用文献数
-
25
A screening system is described that can detect and confirm inhibitors of the late steps of cell wall biosynthesis. The primary high through-put screen monitors induction of β-lactamase following exposure to samples, in an <i>Escherichia coli envA</i>- strain that carries the β-lactamase gene from <i>Citrobacter freundii</i> on a plasmid. Positive samples were detected from compound libraries, from natural products libraries, and from fractions of natural products crude preparations. These samples were then subjected to <i>in vitro</i> assays that could detect the incorporation of soluble cell wall precursor into Lipid I, Lipid II, and polymerized cell wall, using a TLC system that was very accurate and unambiguous in detecting known cell wall inhibitors. One partially purified sample containing a novel antibacterial agent derived from natural products was found to inhibit the formation of Lipid I (50% inhibition at ≤62.5ng/ml), whereas another partially purified sample also derived from natural products inhibited transglycosylation into cell wall polymer (50% inhibition at ≤10μg/ml). This screening system proved to be especially useful because it was sufficiently sensitive and robust to detect inhibitors among samples of crude preparations or varying states of purity.